{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:53Z","timestamp":1788514733000,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["R21AI146804"],"award-info":[{"award-number":["R21AI146804"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaip.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T16:41:21Z","timestamp":1721493681000},"page":"2889-2896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Updates on the Natural History and Clinical Characteristics of NSAID-ERD"],"prefix":"10.1016","volume":"12","author":[{"given":"Anastasia","family":"Jermihov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"iAkushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-2483","authenticated-orcid":false,"given":"Elina","family":"Jerschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.07.013_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2024.07.013_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2024.07.013_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.07.013_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/alr.22516","article-title":"Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay","volume":"10","author":"Kshirsagar","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.07.013_bib7","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.jaip.2023.07.035","article-title":"Sex, ethnicity, body mass index, and environmental exposures associated with NSAID-exacerbated respiratory disease symptom sequence","volume":"11","author":"Dages","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2016.05.048","article-title":"Automated identification of an aspirin-exacerbated respiratory disease cohort","volume":"139","author":"Cahill","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.12.1116","article-title":"Estimated prevalence of AERD in patients with diagnosis of asthma identified with a symptom-based assessment questionnaire","volume":"137","author":"Akenroye","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","article-title":"The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: a work group report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy","volume":"147","author":"Stevens","year":"2021","journal-title":"Asthma & Immunology. J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/all.15067","article-title":"Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID- ERD: results from two randomized placebo-controlled phase 3 trials","volume":"77","author":"Mullol","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2024.07.013_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D\u2082: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.07.013_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rmed.2018.01.002","article-title":"Aspirin-exacerbated respiratory disease: current topics and trends","volume":"135","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2024.07.013_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00405-016-4366-x","article-title":"Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study","volume":"274","author":"Gudziol","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2024.07.013_bib22","doi-asserted-by":"crossref","first-page":"00462","DOI":"10.1183\/23120541.00462-2021","article-title":"NSAID-exacerbated respiratory disease: a population study","volume":"8","author":"Anders\u00e9n","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2024.07.013_bib23","article-title":"Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions","volume":"3","author":"Jerschow","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2024.07.013_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12296","article-title":"Risk factors of NSAID-exacerbated respiratory disease: a population-based study","volume":"13","author":"Helev\u00e4","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaip.2017.04.035","article-title":"Smoking cessation as a possible risk factor for the development of aspirin-exacerbated respiratory disease in smokers","volume":"6","author":"Hayashi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib26","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1016\/j.jaip.2021.06.013","article-title":"Defining the allergic endotype of chronic rhinosinusitis by structured histopathology and clinical variables","volume":"9","author":"Brown","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2024.07.013_bib28","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2500\/ajra.2012.26.3738","article-title":"Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review","volume":"26","author":"Fan","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaip.2015.11.031","article-title":"African American patients with chronic rhinosinusitis have a distinct phenotype of polyposis associated with increased asthma hospitalization","volume":"4","author":"Mahdavinia","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1081-1206(10)61702-4","article-title":"The epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study","volume":"92","author":"Osborne","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.07.013_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.07.013_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.anai.2011.09.022","article-title":"Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease","volume":"108","author":"Chang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02770903.2013.773009","article-title":"Passive smoking induces leukotriene production in children: influence of asthma","volume":"50","author":"Hern\u00e1ndez-Alv\u00eddrez","year":"2013","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2024.07.013_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218386","article-title":"Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage","volume":"14","author":"McElroy","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.07.013_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147326","article-title":"Aspirin- exacerbated respiratory disease polymorphisms; a review study","volume":"870","author":"Fathollahpour","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.jaip.2024.07.013_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.iac.2016.06.010","article-title":"Genetic and epigenetic components of aspirin-exacerbated respiratory disease","volume":"36","author":"Dahlin","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.07.013_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/01902148.2017.1358776","article-title":"Physiopathology and genetics in aspirin-exacerbated respiratory disease","volume":"43","author":"Pav\u00f3n-Romero","year":"2017","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.jaip.2024.07.013_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1398-9995.2010.02514.x","article-title":"Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics","volume":"66","author":"Cheong","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2020.04.064","article-title":"Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease","volume":"147","author":"Haimerl","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib44","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1007\/s00018-019-03393-x","article-title":"Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesis","volume":"77","author":"Romp","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaip.2024.07.013_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imm.13449","article-title":"Staphylococcus aureus controls eicosanoid and specialized pro-resolving mediator production via lipoteichoic acid","volume":"166","author":"Miek","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jaip.2024.07.013_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.plefa.2017.01.008","article-title":"Pseudomonas aeruginosa produces aspirin insensitive eicosanoids and contributes to the eicosanoid profile of polymicrobial biofilms with Candida albicans","volume":"117","author":"Fourie","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jaip.2024.07.013_bib47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/mmy\/myab015","article-title":"Role of the high-affinity reductive iron acquisition pathway of Candida albicans in prostaglandin E2 production, virulence, and interaction with Pseudomonas aeruginosa","volume":"59","author":"Mochochoko","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaip.2024.07.013_bib48","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/alr.22412","article-title":"Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database","volume":"9","author":"Roland","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.07.013_bib49","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.jaip.2020.06.061","article-title":"Leukotriene-associated rash in aspirin- exacerbated respiratory disease","volume":"8","author":"Laidlaw","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anai.2016.10.018","article-title":"Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease","volume":"118","author":"Pelletier","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib51","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaip.2016.04.028","article-title":"Eosinophilia-associated coronary artery vasospasm in patients with aspirin-exacerbated respiratory disease","volume":"4","author":"Shah","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaip.2019.08.054","article-title":"Perimenstrual asthma in aspirin-exacerbated respiratory disease","volume":"8","author":"Eid","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/alr.22168","article-title":"Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease","volume":"8","author":"Glicksman","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.07.013_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.anai.2023.06.002","article-title":"Characterization of alcohol- induced respiratory symptoms in aspirin-exacerbated respiratory disease","volume":"131","author":"Ramos","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib56","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaip.2015.06.018","article-title":"Symptom-based clustering in chronic rhinosinusitis relates to history of aspirin sensitivity and postsurgical outcomes","volume":"3","author":"Divekar","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jaip.2024.07.013_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2500\/ajr.2007.21.2909","article-title":"Intracranial polyps in patients with Samter's triad","volume":"21","author":"Majithia","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2024.07.013_bib59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/MAO.0b013e318259522f","article-title":"Aural polyps in Samter's triad: case report and literature review","volume":"33","author":"Shen","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.jaip.2024.07.013_bib60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib61","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cea.14157","article-title":"Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life","volume":"52","author":"Tchekmedyian","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID- exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","article-title":"Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease","volume":"109","author":"Bochenek","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2024.07.013_bib64","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaip.2024.01.029","article-title":"Absolute eosinophil counts in aspirin-exacerbated respiratory disease are distinctly elevated and correlate inversely with respiratory function","volume":"12","author":"Supron","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1288\/00005537-198702000-00009","article-title":"Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa","volume":"97","author":"Jung","year":"1987","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2024.07.013_bib67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","article-title":"Impaired E prostanoid2 expression and resistance to prostaglandin e2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease","volume":"54","author":"Cahill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2024.07.013_bib69","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.07.013_bib70","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2007.02806.x","article-title":"Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity","volume":"37","author":"Celik","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.013_bib71","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2022.102474","article-title":"Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis","volume":"184","author":"Nordstr\u00f6m","year":"2022","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jaip.2024.07.013_bib73","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaci.2020.04.031","article-title":"Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease","volume":"147","author":"Stevens","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.850494","article-title":"Comprehensive analysis of nasal polyps reveals a more pronounced type 2 transcriptomic profile of epithelial cells and mast cells in aspirin-exacerbated respiratory disease","volume":"13","author":"Bangert","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151685","article-title":"15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation","volume":"132","author":"Nagasaki","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.07.013_bib76","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jaci.2023.06.028","article-title":"Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD","volume":"152","author":"Badrani","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib77","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.013_bib78","doi-asserted-by":"crossref","first-page":"AB384","DOI":"10.1016\/j.jaci.2016.12.924","article-title":"Efficacy of zileuton in patients with asthma and history of aspirin sensitivity: a retrospective analysis of data from two phase 3 studies","volume":"139","author":"Laidlaw","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2021.103227","article-title":"Long-term role of zileuton in the treatment of chronic rhinosinusitis in aspirin exacerbated respiratory disease","volume":"43","author":"Makary","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaip.2024.07.013_bib80","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.jaip.2024.07.013_bib81","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","article-title":"Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges","volume":"66","author":"Stevenson","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.013_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247871","article-title":"Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: a systematic review of the literature and meta-analysis","volume":"16","author":"Eraso","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.07.013_bib83","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0194599814545750","article-title":"Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease","volume":"151","author":"Cho","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2024.07.013_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","article-title":"Long-term effects of aspirin desensitization\u2014treatment for aspirin-sensitive rhinosinusitis-asthma","volume":"85","author":"Sweet","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982400744X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982400744X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T20:39:48Z","timestamp":1732135188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982400744X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S221321982400744X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.07.013","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the Natural History and Clinical Characteristics of NSAID-ERD","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}